Frazier Life Sciences Management, L.P. - REVOLUTION MEDICINES INC ownership

REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 140 filers reported holding REVOLUTION MEDICINES INC in Q2 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.8%.

Quarter-by-quarter ownership
Frazier Life Sciences Management, L.P. ownership history of REVOLUTION MEDICINES INC
ValueSharesWeighting
Q3 2023$27,609,554
+20.8%
997,455
+16.7%
1.83%
+34.4%
Q2 2023$22,857,447
+23.5%
854,4840.0%1.36%
+1.9%
Q1 2023$18,508,123854,4841.34%
Other shareholders
REVOLUTION MEDICINES INC shareholders Q2 2023
NameSharesValueWeighting ↓
Nextech Invest Ltd. 4,839,529$104,824,19843.76%
Column Group LLC 4,577,840$99,156,01435.85%
Mass General Brigham, Inc 338,191$7,3255.71%
Boxer Capital, LLC 4,684,264$101,4614.98%
BVF INC/IL 4,955,588$107,338,0363.92%
DAFNA Capital Management LLC 575,785$12,471,5033.74%
EcoR1 Capital, LLC 5,352,183$115,928,2843.73%
Casdin Capital, LLC 1,810,000$39,204,6003.23%
Artal Group S.A. 2,070,988$44,8582.66%
Integral Health Asset Management, LLC 345,000$7,472,7001.50%
View complete list of REVOLUTION MEDICINES INC shareholders